Private equity firm Aspire Universal and LG Health, have partnered to create a new $300 million fund called the Aspire Ventures Precision Medicine Fund. Each is contributing $15 million to the fund and Aspire is in the process of raising the remainder.
"The term 'precision medicine' has been out there, but it’s really the change in healthcare that’s going on," Essam Abadir, managing partner of...
This week in Paris, companies in the diabetes managment space came together at the Advanced Technologies and Treatments for Diabetes conference to share news and, mostly, a lot of efficacy data. It's an exciting time for the space as closed-loop systems that allow people with diabetes to monitor their glucose continuously and automatically manage their insulin dosing get closer and closer to...
